vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Gogo Inc. (GOGO). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $230.6M, roughly 1.2× Gogo Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -4.3%, a 100.7% gap on every dollar of revenue. On growth, Gogo Inc. posted the faster year-over-year revenue change (67.3% vs 9.4%). Over the past eight quarters, Gogo Inc.'s revenue compounded faster (48.7% CAGR vs 17.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Gogo Inc. is an American provider of in-flight broadband Internet service and other connectivity services for business aircraft, headquartered in Broomfield, Colorado. Through its Gogo LLC subsidiary, Gogo previously provided in-flight WiFi to 17 airlines until the Commercial Air business was sold to Intelsat for $400 million in December 2020. According to Gogo, over 2,500 commercial aircraft and 6,600 business aircraft have been equipped with its onboard Wi-Fi services. The company is the de...
ACAD vs GOGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $230.6M |
| Net Profit | $273.6M | $-10.0M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 6.2% |
| Net Margin | 96.3% | -4.3% |
| Revenue YoY | 9.4% | 67.3% |
| Net Profit YoY | 90.3% | 64.6% |
| EPS (diluted) | $1.61 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $230.6M | ||
| Q3 25 | $278.6M | $223.6M | ||
| Q2 25 | $264.6M | $226.0M | ||
| Q1 25 | $244.3M | $230.3M | ||
| Q4 24 | $259.6M | $137.8M | ||
| Q3 24 | $250.4M | $100.5M | ||
| Q2 24 | $242.0M | $102.1M | ||
| Q1 24 | $205.8M | $104.3M |
| Q4 25 | $273.6M | $-10.0M | ||
| Q3 25 | $71.8M | $-1.9M | ||
| Q2 25 | $26.7M | $12.8M | ||
| Q1 25 | $19.0M | $12.0M | ||
| Q4 24 | $143.7M | $-28.2M | ||
| Q3 24 | $32.8M | $10.6M | ||
| Q2 24 | $33.4M | $839.0K | ||
| Q1 24 | $16.6M | $30.5M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | 87.8% | ||
| Q1 25 | 91.7% | 87.3% | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | 6.2% | ||
| Q3 25 | 12.8% | 12.9% | ||
| Q2 25 | 12.2% | 15.9% | ||
| Q1 25 | 7.9% | 15.3% | ||
| Q4 24 | 59.1% | -17.5% | ||
| Q3 24 | 12.6% | 19.0% | ||
| Q2 24 | 12.6% | 21.2% | ||
| Q1 24 | 7.4% | 33.2% |
| Q4 25 | 96.3% | -4.3% | ||
| Q3 25 | 25.8% | -0.9% | ||
| Q2 25 | 10.1% | 5.7% | ||
| Q1 25 | 7.8% | 5.2% | ||
| Q4 24 | 55.4% | -20.5% | ||
| Q3 24 | 13.1% | 10.6% | ||
| Q2 24 | 13.8% | 0.8% | ||
| Q1 24 | 8.0% | 29.2% |
| Q4 25 | $1.61 | $-0.08 | ||
| Q3 25 | $0.42 | $-0.01 | ||
| Q2 25 | $0.16 | $0.09 | ||
| Q1 25 | $0.11 | $0.09 | ||
| Q4 24 | $0.86 | $-0.22 | ||
| Q3 24 | $0.20 | $0.08 | ||
| Q2 24 | $0.20 | $0.01 | ||
| Q1 24 | $0.10 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $125.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $101.1M |
| Total Assets | $1.6B | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $125.2M | ||
| Q3 25 | $258.0M | $133.6M | ||
| Q2 25 | $253.6M | $102.1M | ||
| Q1 25 | $217.7M | $70.3M | ||
| Q4 24 | $319.6M | $41.8M | ||
| Q3 24 | $155.1M | $176.7M | ||
| Q2 24 | $177.1M | $161.6M | ||
| Q1 24 | $204.7M | $152.8M |
| Q4 25 | $1.2B | $101.1M | ||
| Q3 25 | $917.3M | $107.0M | ||
| Q2 25 | $822.4M | $102.8M | ||
| Q1 25 | $765.2M | $82.9M | ||
| Q4 24 | $732.8M | $69.3M | ||
| Q3 24 | $577.2M | $52.7M | ||
| Q2 24 | $516.7M | $52.0M | ||
| Q1 24 | $464.0M | $62.4M |
| Q4 25 | $1.6B | $1.3B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $976.9M | $810.7M | ||
| Q2 24 | $914.1M | $802.7M | ||
| Q1 24 | $855.1M | $809.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $8.5M |
| Free Cash FlowOCF − Capex | — | $-25.4M |
| FCF MarginFCF / Revenue | — | -11.0% |
| Capex IntensityCapex / Revenue | — | 14.7% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $65.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $8.5M | ||
| Q3 25 | $74.3M | $46.8M | ||
| Q2 25 | $64.0M | $36.7M | ||
| Q1 25 | $20.3M | $32.5M | ||
| Q4 24 | $40.4M | $-38.3M | ||
| Q3 24 | $63.2M | $25.1M | ||
| Q2 24 | $25.0M | $24.9M | ||
| Q1 24 | $29.1M | $29.7M |
| Q4 25 | — | $-25.4M | ||
| Q3 25 | $73.9M | $27.3M | ||
| Q2 25 | — | $33.5M | ||
| Q1 25 | — | $29.7M | ||
| Q4 24 | — | $-42.6M | ||
| Q3 24 | $63.2M | $20.7M | ||
| Q2 24 | — | $21.6M | ||
| Q1 24 | — | $28.2M |
| Q4 25 | — | -11.0% | ||
| Q3 25 | 26.5% | 12.2% | ||
| Q2 25 | — | 14.8% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | — | -30.9% | ||
| Q3 24 | 25.2% | 20.6% | ||
| Q2 24 | — | 21.1% | ||
| Q1 24 | — | 27.0% |
| Q4 25 | — | 14.7% | ||
| Q3 25 | 0.1% | 8.7% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | 0.0% | 4.4% | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | 2.87× | ||
| Q1 25 | 1.07× | 2.70× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | 2.36× | ||
| Q2 24 | 0.75× | 29.74× | ||
| Q1 24 | 1.76× | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
GOGO
| Services | $191.9M | 83% |
| Products | $38.7M | 17% |
| Fcc Reimbursement Program | $2.0M | 1% |
